2019-2020 Quality Improvement Award
The application window for 2019-2020 funding is closed. View application details.
The Department of Internal Medicine Faculty Quality Improvement Award is designed to help develop leaders in quality improvement within the department. To apply, faculty members must propose a quality improvement project, providing a detailed description of the problem the project will attempt to address including the underlying causes of the problem, goals of the proposed project, and a summary of the expected outcomes. Applicants are also required to include the setting and impact, approach, and the significance of the project including how it will improve clinical practice. One award is given per academic year.
Each application is reviewed by a committee consisting of a selection of representatives from the Quality & Innovation Program and the Council. A patient advisor is also included as a member of the review committee. The Review Committee considers the below questions when assessing each application:
- Is the applicant qualified and ready to undertake the project and complete it within 1 year?
- Is the scope of the project something that is achievable by the applicant within the planned setting?
- Does this project have the potential for significant impact on the quality of care for our patients?
- Is the approach described sound and appropriate for achieving the goals of the project?
- Have potential barriers been carefully considered and appropriate strategies to tackling them been identified?
2018-2019 Faculty Quality Improvement Award Recipient
Rajan Ravikumar, MD, Division of Allergy and Clinical Immunology
Our first recipient is Dr. Rajan Ravikumar from the Division of Allergy and Clinical Immunology, whose multi-disciplinary project aims to improve the appropriate use of antibiotics in hospitalized patients. The team, including Dr. Tejal Gandhi from the Division of Infectious Diseases, Dr. David Bozaan from the Division of Hospital Medicine and representatives from pharmacy, nursing, and Health Information and Technology Services (HITS), will evaluate the impact of a penicillin skin-testing protocol designed to help separate out the significant number of patients who report an allergy to penicillin but don’t have a true IgE-mediated reaction to it. The goal is for more patients be safely treated with first-line antibiotics.